Whitehawk Therapeutics (WHWK) Interest Coverage Ratio (2020 - 2024)
Historic Interest Coverage Ratio for Whitehawk Therapeutics (WHWK) over the last 5 years, with Q3 2024 value amounting to 352.97.
- Whitehawk Therapeutics' Interest Coverage Ratio fell 1469.82% to 352.97 in Q3 2024 from the same period last year, while for Jun 2025 it was 2692.87, marking a year-over-year decrease of 78035.86%. This contributed to the annual value of 438.04 for FY2024, which is 4066.84% down from last year.
- As of Q3 2024, Whitehawk Therapeutics' Interest Coverage Ratio stood at 352.97, which was down 1469.82% from 268.69 recorded in Q2 2024.
- Whitehawk Therapeutics' 5-year Interest Coverage Ratio high stood at 11.63 for Q3 2020, and its period low was 556.12 during Q3 2021.
- Over the past 5 years, Whitehawk Therapeutics' median Interest Coverage Ratio value was 284.91 (recorded in 2023), while the average stood at 260.74.
- As far as peak fluctuations go, Whitehawk Therapeutics' Interest Coverage Ratio tumbled by 468226.49% in 2021, and later surged by 5338.4% in 2022.
- Whitehawk Therapeutics' Interest Coverage Ratio (Quarter) stood at 11.63 in 2020, then crashed by 2305.55% to 279.74 in 2021, then grew by 2.97% to 271.44 in 2022, then decreased by 14.49% to 310.77 in 2023, then dropped by 13.58% to 352.97 in 2024.
- Its Interest Coverage Ratio was 352.97 in Q3 2024, compared to 268.69 in Q2 2024 and 336.41 in Q1 2024.